ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...

Diabetic weight-loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Weight-loss products, including items packaged as Ozempic, Wegovy and Mounjaro, have been seized following a number of operations by the Revenue Commissioners.

GLP-1 RA use was linked to a 2.21-fold risk of developing neovascular age-related macular degeneration// (nAMD) * Only 0.2% ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...